Highlights Adynxx, Inc.

Equities

ADYX

US00784D1037

Market Closed - OTC Markets Other stock markets 08:01:06 05/12/2023 pm IST			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		-.--%	-.--%

2019	Adynxx, Inc. announced that it has received $0.45 million in funding	CI
2019	Adynxx, Inc. announced a financing transaction	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adynxx, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2019	14/19/14	CI
Adynxx, Inc. Announces Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2019	14/19/14	CI
Adynxx, Inc. completed the acquisition of Alliqua BioMedical, Inc. in a reverse merger transaction.	03/19/03	CI
Adynxx Provides Clinical Updates	22/19/22	CI
Adynxx and twoXAR Form Collaboration to Discover and Develop Treatments for Endometriosis	15/18/15	CI
Adynxx, Inc. entered into a definitive merger agreement to acquire Alliqua BioMedical, Inc. in a reverse merger transaction.	12/18/12	CI
Adynxx Completes Enrollment in ADYX-004, a Phase 2 Study of Brivoligide	04/17/04	CI
Adynxx, Inc. Initiates ADYX-004, a Phase 2 Study of AYX1, Lead Compound for the Treatment of Post-Surgical Pain	01/17/01	CI
Adynxx Reports Positive Results for Phase 2b Study of AYX1	11/15/11	CI
Adynxx Initiates Phase 2 Dose-Ranging Study of AYX1	16/14/16	CI
Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of its Lead Product Candidate AYX1	05/13/05	CI
Adynxx, Inc. Doses First Patient in Investigational AYX1 Phase 2 Study	27/13/27	CI
Adynxx, Inc. Completes Enrollment in Phase 1 Clinical Study of Lead Therapeutic for Treatment of Pain	07/12/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer